Healthcare artificial intelligence drew roughly $18 billion in venture capital in 2025, accounting for 46% of all healthcare investment that year. For senior living operators and care organizations, shifting this capital into operational efficiency is no longer optional; it is a core margin strategy tied directly to Medicare and Medicaid reimbursement.
Capital concentration and portfolio strategy
"The capital is here and concentrating fast," said Jennifer Sisto Gall, vice president of strategic initiatives at ATI Advisory. She noted that venture capital, private equity, public markets, and government programs are the four primary drivers of this investment.
Venture capital is shifting away from standalone AI startups toward embedding artificial intelligence into tools organizations already use. Private equity firms are taking a broader approach, using these technologies to create value across entire portfolios of healthcare providers. This includes senior living operators, post-acute facilities, behavioral health groups, and value-based care platforms.
For businesses exposed to government reimbursement, this shift requires an AI for Executives & Strategy approach to treat technology as an operating strategy rather than a standalone product.
Federal and state regulatory frameworks
Federal and state programs are actively building the governance infrastructure required to manage these investments. At the federal level, four agencies govern different aspects of AI deployment. The Food and Drug Administration oversees clinical decision-making and medical devices. The Centers for Medicare & Medicaid Services govern AI usage across its programs. The Office of the National Coordinator for Health Information Technology mandates transparency for tools embedded in certified health IT, while the Federal Trade Commission targets unfair or deceptive practices in consumer-facing tools.
"There's an active push in a completely new way to bring a variety of new technologies into the traditional healthcare system via ACOs as a market pathway," said Will Sellheim, managing director of provider strategy and care transformation practice at ATI. The CMS Innovation Center is supporting this through models like ACCESS, WISeR, LEAD, and TEAM, which aim to establish market conditions for AI-powered care delivery at scale.
State governments are moving at different speeds due to varying risk tolerances. More than 280 healthcare AI bills were introduced nationwide in 2026. Utah is piloting a program allowing AI to refill medications with a human doctor in the loop. Conversely, Pennsylvania recently filed a lawsuit against an AI company accused of impersonating a psychiatrist during patient treatments.
Senior living outpaces larger health systems
Senior living communities are currently outpacing some larger health systems in AI adoption. Their smaller size allows for greater agility in deploying new systems.
Many states have spent the past decade overhauling legacy systems. Operators are now using AI for Healthcare to accelerate this process, allowing technology to handle routine administrative tasks while human staff focus on building new infrastructure.
"Seeing AI deployed in senior living communities to improve outcomes for more complex populations is exciting as operators connect residents to the care they need," said Rose Mollitor, managing director at ATI.
Why this matters for healthcare professionals
Healthcare professionals must recognize that artificial intelligence is now a direct component of margin management and regulatory compliance. Leaders should assess whether their current vendor contracts and internal workflows account for the new CMS models and state-level transparency requirements. Treating AI as an operational strategy, rather than a discrete IT purchase, will determine which organizations maintain reimbursement viability in the coming years.
Your membership also unlocks:
